Back to Search Start Over

Acquired Aseptic Intracardiac Shunts Following Transcatheter Aortic Valve Replacement: A Systematic Review.

Authors :
Rojas P
Amat-Santos IJ
Cortés C
Castrodeza J
Tobar J
Puri R
Sevilla T
Vera S
Varela-Falcón LH
Zunzunegui JL
Gómez I
Rodés-Cabau J
San Román JA
Source :
JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2016 Dec 26; Vol. 9 (24), pp. 2527-2538. Date of Electronic Publication: 2016 Nov 23.
Publication Year :
2016

Abstract

Objectives: The aim of this study was to describe the incidence, mechanisms, features, and management of aseptic intracardiac shunts (AICS).<br />Background: AICS following transcatheter aortic valve replacement (TAVR) are an uncommon and barely described complication.<br />Methods: A systematic review was performed of all published cases of AICS following TAVR, and the incidence, predictors, main features, management, and related outcomes were analyzed.<br />Results: A total of 31 post-TAVR AICS were gathered. After excluding transapical fistulas, the 28 remaining cases corresponded with an incidence of about 0.5%. Mean age and mean logistic European System for Cardiac Operative Risk Evaluation score were 80 ± 11 years and 19.2 ± 8.3%, respectively. Prior radiation therapy for cancer was present in 14.3%, and 42.8% had severe calcification of the aortic valve. TAVR was undertaken using balloon-expandable prostheses in the majority of cases (85.7%), via the transapical approach in one-third. Median time from TAVR to diagnosis was 21 days (interquartile range: 7 to 30 days), with intraprocedural suspicion in 12 cases (42.9%) and a mean Q <subscript>p</subscript> /Q <subscript>s</subscript> ratio of 1.8 ± 0.6. The most common location for AICS was the interventricular septum (60.7%). Heart failure was frequent (46.4%), but 14 patients (50%) remained asymptomatic. Medical treatment (71.4%) was associated with poor outcomes (30-day mortality rate 25%), especially in symptomatic patients (35% vs. 0%; p = 0.020) and in those with higher Q <subscript>p</subscript> /Q <subscript>s</subscript> ratios (1.9 ± 0.6 vs. 1.4 ± 0.1), while cardiac surgery (3.6%), and percutaneous closure (25%) led to good outcomes after a median follow-up period of 3 months (interquartile range: 1 to 9 months).<br />Conclusions: Post-TAVR AICS are uncommon but have high 30-day mortality if left untreated, especially in symptomatic patients. Percutaneous closure was feasible and safe in symptomatic patients but remains controversial in asymptomatic subjects.<br /> (Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1876-7605
Volume :
9
Issue :
24
Database :
MEDLINE
Journal :
JACC. Cardiovascular interventions
Publication Type :
Academic Journal
Accession number :
27889349
Full Text :
https://doi.org/10.1016/j.jcin.2016.09.034